NCT02250482 - An Open Study to Investigate the Safety and Efficacy of Optivate® in Haemophilia A Patients Undergoing Surgery. | Biotech Hunter

Timeline

Start Date

November 30, 2001

Primary Completion Date

August 31, 2003

Conditions

Haemophilia A

Interventions

BIOLOGICAL

Optivate® (Human Coagulation Factor VIII)

Trial Locations (8)

Klinika Haematologii, Akademia Medyczna w Gdansku, ul., Debinki 7, 80-211 Gdansk

Klinika Haematologii, Akademia Medyczna w Lublinie, ul., Dr K Jaczewskiego 8, 20-090, Lublin

Klinika Haematologii, Akademia Medyczna w Poznaniu, ul., Szkolna 8/12, 61-833 Poznan

Haemophilia Centre, Addenbrooke's Hospital, Hills Road, Cambridge

Haemophilia Centre, University Dept. of Haemophilia, Manchester Royal Infirmary, Manchester

Haemophilia Centre, University Hospital, Queens Medical Centre, Clifton Boulevard, Nottingham

Sheffield Haemophilia & Thrombosis Centre, Royal Hallamshire Hospital, Glossop Road, Sheffield

Haemophilia Centre, Southampton General Hospital, Tremona Road, Southampton